Portfolio (Quarterly)
Guide ↗
TANG CAPITAL MANAGEMENT LLC
· CIK 0001232621| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | 11,329,500.0 | $180.7M | 8.93% | — | — | $15.95 | -4.2% |
| 2 | GLPG | GALAPAGOS NV | Healthcare | 3,921,219.0 | $128.2M | 6.33% | -230K | -5.5% | $32.70 | -15.9% |
| 3 | PTCT | PTC THERAPEUTICS INC | Healthcare | 1,500,000.0 | $113.9M | 5.63% | — | — | $75.96 | -4.3% |
| 4 | CELC | CELCUITY INC | Healthcare | 1,050,000.0 | $104.7M | 5.17% | -100K | -8.7% | $99.74 | +38.0% |
| 5 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 1,236,027.0 | $97.6M | 4.82% | — | — | $78.99 | +41.0% |
| 6 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 1,188,624.0 | $97.3M | 4.81% | -1.3M | -51.6% | $81.88 | -20.4% |
| 7 | — | KINIKSA PHARMACEUTICALS INTL | — | 2,259,889.0 | $93.2M | 4.61% | -69K | -3.0% | $41.25 | — |
| 8 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 2,628,538.0 | $91.2M | 4.51% | +323K | +14.0% | $34.71 | -17.1% |
| 9 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 16,790,809.0 | $90.2M | 4.45% | — | — | $5.37 | -65.4% |
| 10 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 4,573,530.0 | $73.9M | 3.65% | -468K | -9.3% | $16.15 | +65.7% |
| 11 | — | AVIDITY BIOSCIENCES INC | — | 900,000.0 | $64.9M | 3.21% | NEW | — | $72.13 | — |
| 12 | ANAB | ANAPTYSBIO INC | Healthcare | 1,332,087.0 | $64.6M | 3.19% | — | — | $48.48 | +30.3% |
| 13 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 1,892,200.0 | $62.0M | 3.06% | -1.3M | -40.9% | $32.76 | +130.9% |
| 14 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 1,792,626.0 | $55.8M | 2.76% | -1.1M | -36.9% | $31.12 | -45.2% |
| 15 | CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | 1,700,000.0 | $49.1M | 2.42% | NEW | — | $28.86 | -0.2% |
| 16 | BNTX | BIONTECH SE | Healthcare | 470,000.0 | $44.7M | 2.21% | +200K | +74.1% | $95.20 | -5.9% |
| 17 | ANIP | ANI PHARMACEUTICALS INC | Healthcare | 481,437.0 | $38.0M | 1.88% | +164K | +51.6% | $78.94 | -1.2% |
| 18 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 80,000.0 | $36.3M | 1.79% | — | — | $453.36 | -0.7% |
| 19 | NUVB | NUVATION BIO INC | Healthcare | 3,857,457.0 | $34.6M | 1.71% | -343K | -8.2% | $8.96 | -47.3% |
| 20 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 700,000.0 | $26.7M | 1.32% | — | — | $38.21 | +15.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
96.6%
Technology
1.3%
Financial Services
1.1%
Communication Services
0.9%
Real Estate
0.1%